Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur Ellen A NOHR |
Documents disponibles écrits par cet auteur (1)
Faire une suggestion Affiner la recherche
Preconceptional and prenatal supplementary folic acid and multivitamin intake and autism spectrum disorders / Jasveer VIRK in Autism, 20-6 (August 2016)
[article]
Titre : Preconceptional and prenatal supplementary folic acid and multivitamin intake and autism spectrum disorders Type de document : Texte imprimé et/ou numérique Auteurs : Jasveer VIRK, Auteur ; Zeyan LIEW, Auteur ; Jørn OLSEN, Auteur ; Ellen A NOHR, Auteur ; Janet M CATOV, Auteur ; Beate RITZ, Auteur Article en page(s) : p.710-718 Langues : Anglais (eng) Mots-clés : autism spectrum disorders environmental factors Index. décimale : PER Périodiques Résumé : Objective: To evaluate whether early folic acid supplementation during pregnancy prevents diagnosis of autism spectrum disorders in offspring.Methods: Information on autism spectrum disorder diagnosis was obtained from the National Hospital Register and the Central Psychiatric Register. We estimated risk ratios for autism spectrum disorders for children whose mothers took folate or multivitamin supplements from 4?weeks prior from the last menstrual period through to 8?weeks after the last menstrual period (?4 to 8?weeks) by three 4-week periods.Results: We did not find an association between early folate or multivitamin intake for autism spectrum disorder (folic acid—adjusted risk ratio: 1.06, 95% confidence interval: 0.82–1.36; multivitamin—adjusted risk ratio: 1.00, 95% confidence interval: 0.82–1.22), autistic disorder (folic acid—adjusted risk ratio: 1.18, 95% confidence interval: 0.76–1.84; multivitamin—adjusted risk ratio: 1.22, 95% confidence interval: 0.87–1.69), Asperger’s syndrome (folic acid—adjusted risk ratio: 0.85, 95% confidence interval: 0.46–1.53; multivitamin—adjusted risk ratio: 0.95, 95% confidence interval: 0.62–1.46), or pervasive developmental disorder–not otherwise specified (folic acid—adjusted risk ratio: 1.07, 95% confidence interval: 0.75–1.54; multivitamin: adjusted risk ratio: 0.87, 95% confidence interval: 0.65–1.17) compared with women reporting no supplement use in the same period.Conclusion: We did not find any evidence to corroborate previous reports of a reduced risk for autism spectrum disorders in offspring of women using folic acid supplements in early pregnancy. En ligne : http://dx.doi.org/10.1177/1362361315604076 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=290
in Autism > 20-6 (August 2016) . - p.710-718[article] Preconceptional and prenatal supplementary folic acid and multivitamin intake and autism spectrum disorders [Texte imprimé et/ou numérique] / Jasveer VIRK, Auteur ; Zeyan LIEW, Auteur ; Jørn OLSEN, Auteur ; Ellen A NOHR, Auteur ; Janet M CATOV, Auteur ; Beate RITZ, Auteur . - p.710-718.
Langues : Anglais (eng)
in Autism > 20-6 (August 2016) . - p.710-718
Mots-clés : autism spectrum disorders environmental factors Index. décimale : PER Périodiques Résumé : Objective: To evaluate whether early folic acid supplementation during pregnancy prevents diagnosis of autism spectrum disorders in offspring.Methods: Information on autism spectrum disorder diagnosis was obtained from the National Hospital Register and the Central Psychiatric Register. We estimated risk ratios for autism spectrum disorders for children whose mothers took folate or multivitamin supplements from 4?weeks prior from the last menstrual period through to 8?weeks after the last menstrual period (?4 to 8?weeks) by three 4-week periods.Results: We did not find an association between early folate or multivitamin intake for autism spectrum disorder (folic acid—adjusted risk ratio: 1.06, 95% confidence interval: 0.82–1.36; multivitamin—adjusted risk ratio: 1.00, 95% confidence interval: 0.82–1.22), autistic disorder (folic acid—adjusted risk ratio: 1.18, 95% confidence interval: 0.76–1.84; multivitamin—adjusted risk ratio: 1.22, 95% confidence interval: 0.87–1.69), Asperger’s syndrome (folic acid—adjusted risk ratio: 0.85, 95% confidence interval: 0.46–1.53; multivitamin—adjusted risk ratio: 0.95, 95% confidence interval: 0.62–1.46), or pervasive developmental disorder–not otherwise specified (folic acid—adjusted risk ratio: 1.07, 95% confidence interval: 0.75–1.54; multivitamin: adjusted risk ratio: 0.87, 95% confidence interval: 0.65–1.17) compared with women reporting no supplement use in the same period.Conclusion: We did not find any evidence to corroborate previous reports of a reduced risk for autism spectrum disorders in offspring of women using folic acid supplements in early pregnancy. En ligne : http://dx.doi.org/10.1177/1362361315604076 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=290